Browse All Trials

  • Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
  • Radiation Therapy With Either Capecitabine or Fluorouracil Before Surgery in Treating Patients With Resectable Rectal Cancer (NSABP-R-04)
  • Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma
  • Study of Adjuvant Radiochemotherapy for Gastric Cancer
  • Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-Up of Nasopharyngeal Carcinoma.
  • Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
  • A Quality of Life Study re Management of Malignant Pleural Effusions
  • Treatment of Children With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
  • Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.
  • A Study of Intensity Modulated Radiation Therapy for Pelvic Lymph Nodes and Primary Tumour in Patients with Prostate Cancer
  • Safety Study of the Proteasome Inhibitor PR-171 in Patients With Hematological Malignancies (PX-171)
  • 3D-Conformal Radiation vs Helical Tomotherapy in Prostate Cancer
  • Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Patients With Hemophagocytic Lymphohistiocytosis (EU-20619)
  • Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
  • Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy
  • Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumours
  • Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
  • Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma
  • CPT-11 (Irinotecan), Oxaliplatin and Xeloda (COX) in Patients with Advanced Colorectal Cancer
  • Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms Tumour
  • Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
  • Collecting and Banking Pediatric Brain Tumour Research Specimens
  • Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms Tumour
  • Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
  • A Phase I/II Study of Concurrent Pemetrexed/Cisplatin/Radiation in Stage IIIA/B Non-Small Cell Lung Cancer
  • Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
  • Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
  • Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
  • Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumour
  • A Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma
  • Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme
  • Adjunctive Efficacy Study Of The SoftScan® Optical Breast Imaging System
  • Radiation Therapy Using Helical Tomotherapy IMRT for Head and Neck Cancer
  • Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia
  • The Effect of Radiation on Semen Quality and Fertility in Men With Prostate Cancer
  • Dynamic Breast MRI in Assessing Locally Advanced Breast Cancer
  • A Pilot Study To Evaluate the Effectiveness of Pulsed Time-Domain Optical Spectroscopy for Monitoring the Responses in Neoadjuvant Treatments of Locally-Advanced Breast Cancer
  • Pilot Investigation of Ultrasound Imaging and Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Locally-Advanced Breast Cancer Response to Neoadjuvant Treatment
  • Preoperative Treatment of Patients With High Risk Thymoma
  • Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumours or High-Risk Medulloblastoma
  • Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
  • Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
  • Radiation Therapy and Androgen Deprivation Therapy in Treating Patients Who Have Undergone Surgery for Prostate Cancer (RADICALS)
  • Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
  • Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
  • Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising PSA After Surgery for Prostate Cancer
  • Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma
  • Iodine I 131 Metaiodobenzylguanidine and a Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory High-Risk Neuroblastoma
  • Exploring the Role of 3T MRI in Gamma Knife Radiosurgery
  • Kidney and Blood Pressure Changes in Patients Receiving Bevacizumab, Aflibercept, Sunitinib, or Cediranib for Cancer
  • Randomized Phase III Study of Optimal Sequencing of Hormonal Therapy and Radiation in Patients with T1-T3 Prostate Cancer
  • Combined Resection of Colorectal Metastases
  • Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
  • Does Palliative Chemotherapy Improve Symptoms in Women with Recurrent Ovarian Cancer?
  • Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia
  • Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance
  • Pap Smear Research Study
  • Temozolomide and Oral VP-16
  • Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
  • Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality
  • MRI-Guided Biopsy of Recurrent Prostate Cancer After Radiation Therapy
  • A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer
  • Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca
  • Salvage Prostatectomy After Radiation Therapy
  • Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (8669-007)
  • Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
  • A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumours (MK-1775-001 AM7)
  • Neuropsychological and Behavioural Testing in Young Patients With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumour (PNET)
  • Online Psychoeducational Intervention Program
  • TEM Prostate
  • Perfexion Brain Metastasis
  • Short Neoadjuvant Hemithoracic IMRT for MPM
  • Sorafenib Long Term Extension Program (STEP)
  • Phase 1 Study Evaluating the Integration of Hypofractional Renal Ablative Radiation Therapy in the Setting of Metastatic Renal Cell Carcinoma
  • The Effects of Chemotherapy on Cognition
  • Does Performing a Confirmatory Tumour Biopsy in Patients with Metastatic Breast Cancer Alter their Management?
  • DCIS Permanent Breast Seed Implant
  • Health Education Materials With or Without a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer
  • Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma
  • Study of Antioxidants on Prostate Tumours in Men Undergoing Radical Prostatectomy for Prostate Cancer
  • A Pilot Study of Gentiana  lutea (radix), Zingiber officinalis, and Curcuma longa for the Treatment of Anorexia in Cancer Patients
  • Sterotactic Body Radiation Therapy for Unresectable Liver Metastases from Colorectal Cancer
  • Sterotactic Body Radiation Therapy for Unresectable Hepatocellular Cancer
  • Multi-Modality Radiation Treatment Planning for Malignant Glioma
  • Pharmacogenetic Study of Irinotecan Chemotherapy
  • A Phase II Study of Dexamethasone in the Prophylaxis of Radiation-Induced Pain Flare
  • Sorafenib in patients with metastatic Renal Cell cancer resistant to Sutent
  • Cisplatin/Docetaxel Chemotherapy With Concurrent Thoracic Radiotherapy In Advanced Loco-Regional Non-Small Cell Lung Cancer
  • Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study
  • Study of Late-Occurring Complications in Childhood Cancer Survivors
  • Acetaminophen for Cancer Pain
  • Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumour
  • Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism
  • Chemotherapy and Radiation Therapy Compared With Radiation Therapy Alone in Treating Patients With High-Risk Stage I, Stage II, or Stage III Endometrial Cancer
  • Community Based Exercise Program for Well Cancer Survivors
  • N99-02: Melphalan and Buthionine Sulfoximine Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Children With Resistant or Recurrent Neuroblastoma
  • Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers
  • Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer
  • Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumours
  • Prospective Identification of Risk Factors for Skeletal Related Events in Breast Cancer Patients Receiving Bisphosphonates for Bone Metastases
  • Reform: A Randomised Pilot Study Comparing the Efficacy of 4-weekly versus 12-weekly intravenous Bisphosphonate Therapy in Women with low risk Bone Metastases from Breast Cancer using bone resorption markers
  • A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma
  • Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behaviour Through Machine Learning Analysis of Advanced Imaging Technology
  • Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours
  • Effect of an Oral Supplement on the Total Energy and Protein Intake of Head and Neck Cancer Patients in the Last 2 Weeks of Radiation Therapy
  • Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer.
  • Complete Lymph Node Dissection or Observation in Treating Patients With Localized Melanoma and Sentinel Node Metastasis Who Have Undergone Sentinel Lymphadenectomy
  • The Utility of FDG-PET for Radiation Treatment in NSCLC
  • A Pilot Study to Evaluate the Feasibility of Combining Submandibular Salivary Gland Tx & IMRT Tomo to Reduce Xerostomia
  • A Multicentre Clinical Study of the Sonablate®500 for the Treatment of Locally Recurrent Prostate Cancer With HIFU
  • Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial
  • Comparative 2-D Tumour Analysis in Familial Gliomas
  • Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment
  • An Imaging Pilot Study of 18F-fluoro-3'-Deoxy-3'-L-fluorothymidine (18F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine
  • Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and Biomarkers
  • Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating
  • A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy
  • Magnetic Resonance (MR) Spectroscopy in Localized Prostate Cancer
  • A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA
  • A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast Cancer
  • The Effects of Exercise Training on the Health-related Fitness of Colon Cancer Survivors
  • Parent-Delivered Massage in Paediatric Cancer
  • Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiation Therapy or Chemo-radiotherapy
  • Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
  • Reconstruction Following Pancreaticoduodenectomy: A Randomized Clinical Trial of Pancreaticojejunostomy vs Pancreaticogastomy
  • Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy
  • Hypofractionated Accelerated Post-Operative Radiation Therapy For Prostate Cancer
  • Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash
  • Phase II Study of Neoadjuvant Taxotere, Cisplatin, and 5-Fluorouracil in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
  • A comprehensive study of QOL and fatigue in patients with AML (AML QOL Fatigue)
  • Cisplatin, Etoposide, and Two Different Schedules of Radiation Therapy in Treating Patients With Limited Stage Small Cell Lung Cancer
  • Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
  • Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
  • A Study to Assess the effect of IMN 1207 vs Casein on survival, weight loss and quality of life in non-small cell lung cancer patients during or following chemotherapy, RT or surgery
  • Concurrent Once-daily Versus twice-daily Radiation Therapy
  • A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumours)
  • Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumour of the Central Nervous System
  • Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery
  • Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
  • Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
  • Cone Beam Computed Tomography (CT) Bladder
  • High-Dose-Rate Brachytherapy
  • Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2)
  • Automating Breast Radiation Therapy (RT)
  • Palliative Radiation Therapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4)
  • Randomized Phase III Trial Of Doxorubicin/Cisplatin/Paclitaxel And G-CSF Versus Carboplatin/Paclitaxel In Patients With Stage III & IV Or Recurrent Endometrial Cancer
  • Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients
  • Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy
  • Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
  • Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumour
  • Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma
  • Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
  • PF-00299804 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Standard Therapy for Advanced or Metastatic Cancer
  • Phase I/II Study of Fractionated Stereotactic Radiation Therapy for Early Stage Non-Small Cell Lung Cancer
  • Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC
  • Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial)
  • One-stage Breast Reconstruction Using Dermal Matrix/Implant Versus Two-stage Expander/Implant Procedure
  • A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (Sunitinib Prospective Cardiovascular Effect)
  • Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
  • Stereotactic Radiosurgery With Sunitinib for Brain Metastases
  • Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
  • Biomarkers in Tumour Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
  • Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
  • Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
  • Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research
  • Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
  • Study of Kidney Tumours in Young Patients
  • Collecting and Storing Samples of Blood and Tumour Tissue From Patients With Osteosarcoma
  • Collecting and Storing Blood and Brain Tumour Tissue Samples From Children With Brain Tumours
  • Colorectal Cancer Screening for Cancer Survivors
  • A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
  • Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumour, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
  • Cryoablation Versus Radiofrequency Ablation for Small Renal Masses
  • Radiation Therapy With or Without Temozolomide in Treating Patients With Anaplastic Glioma
  • A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
  • Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
  • Safety and Efficacy of Iron Reduction by Phlebotomy
  • Comparing Three Combination Chemotherapy Regimens in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
  • The Timing of SU11248 Treatment in Patients With Metastatic Renal Cell Carcinoma
  • CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
  • Colposcopy Versus HPV Testing to Identify Persistent Cervical Precancers
  • Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
  • Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
  • Study to Identify Mechanisms of Resistance to Standard Therapy in Patients With Metastatic Colorectal Cancer
  • Non-invasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI)
  • Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer
  • A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib)
  • Prostate cancer study of CRT + Upfront ADT vs. PHPC + Salvage ADT
  • Trial of an Augmented Mobilization Strategy With Plerixafor (Mozobil®) in a Population at Risk for Poor Stem Cell Mobilization
  • An Alternative to A Fixed Schedule In Management Of Prostate Cancer
  • Efficacy of Ultrasound Contrast Agent to Assess Renal Masses
  • Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic Castration Resistant Prostate Cancer
  • Assessment of Ovarian Reserve in Female Cancer Survivors
  • Laparoscopic Approach to Cervical Cancer
  • Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab
  • Irinotecan pharmacogenomics
  • Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
  • Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
  • CTC Pros
  • Reducing Pain and Disability After Breast Cancer Surgery
  • MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer
  • Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
  • Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
  • Randomized Anastrozole Exercise Trial (RAE)
  • Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma
  • Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment
  • Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
  • Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast
  • MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy
  • Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumours, Lymphoma, or Leukemia
  • A Registry Study of Permanent Breast Seed Implant
  • Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma
  • A Study of MK1775 in Combination With Topotecan/Cisplatin in Patients With Cervical Cancer (1775-008)
  • A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
  • TEM Timing
  • Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
  • 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology
  • Study of Vorinostat (MK0683), an HDAC Inhibitor, in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (0683-095)
  • A Randomized Phase III Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer
  • Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
  • Open-Label Study of Lenalidomide in Combination With Oral Dexamethasone in the Treatment of Previously Untreated, Symptomatic Patients With Chronic Lymphocytic Leukemia
  • A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumour Patients
  • Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
  • Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma
  • Involved Field Radiation Therapy for Non-gastric Marginal Zone Lymphoma
  • Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy
  • Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
  • Collecting and Storing Tissue From Young Patients With Cancer
  • A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation
  • A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
  • Local Anesthetic Wound Infusion and Functional Recovery After Colon Surgery
  • Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)
  • Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
  • A Study of Foretinib in Patients With Recurrent/Metastatic Breast Cancer
  • Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
  • Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
  • Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer
  • Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer
  • LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
  • Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia
  • Compassionate Use Trial for Unresectable Melanoma With Ipilimumab
  • A Study of R04929097 in Combination With Gemcitabine in Patients With Advanced Solid Tumours
  • Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers
  • Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent Therapy
  • Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation
  • Art Therapy Intervention for Breast Cancer Patients
  • The Triumph Study
  • Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma
  • Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
  • A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma
  • Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin in Subjects With Non-Hodgkin's Lymphoma
  • Multicentre Selective Lymphadenectomy Trial II (MSLT-II)
  • Ofatumumab and Bendamustine Combination Therapy Compared With Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin's Lymphoma (NHL) Unresponsive to Rituximab or a Rituximab-Containing Regimen
  • DCE-CT Imaging
  • Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumours
  • Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
  • ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Subjects With KRAS Wild-Type Metastatic Colorectal Cancer
  • A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
  • Oncology Treatment Decisions
  • Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer
  • A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases
  • A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+RO5072759 (GA101) in Patients With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)
  • First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.
  • Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer
  • Single Agent Ofatumumab Vs. Single Agent Rituximab in Follicular Lymphoma Relapsed After Rituximab-Containing Therapy
  • Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
  • A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer
  • Study Comparing Orteronel Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
  • Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma
  • Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
  • Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure Patients
  • Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver Metastases
  • A Phase II Study of Oral Panobinostat (LBH589) and Rituximab to Treat Diffuse Large B Cell Lymphoma
  • Lifestyle Intervention for Polycystic Ovary Syndrome: Pulse-Based Diet and Exercise
  • Focal MR-Guided Focused Ultrasound Treatment of Localized Low-Risk Prostate Cancer: Feasibility Study
  • Cediranib Maleate With or Without Lenalidomide in Treating Patients With Thyroid Cancer
  • Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors
  • A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung
  • Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia
  • Radiation Therapy or Radiation Therapy and Temozolomide or Temozolomide Alone in Treating Patients With Newly Diagnosed Anaplastic Glioma
  • Study of Intratumoural Hypoxia Using Pre-operative Administration of Pimonidazole
  • Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
  • Optimum Timing for Surgery After Pre-operative Radiotherapy
  • A Study on the Timing of FOLFOX for Patients With Operable, Node Positive Rectal Cancer
  • A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
  • Living With Hope Program for Rural Women Caregivers
  • A Randomized Clinical Trial of Megestrol Acetate as an Appetite Stimulant in Malnourished Children With Cancer
  • Osteonecrosis in Children With Acute Lymphoblastic Leukemia
  • Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients
  • A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
  • Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
  • Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
  • Vinorelbine Ditartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
  • Dexamethasone vs Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiation Therapy for Bone Metastases
  • A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer
  • External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumours and High-Grade Astrocytomas
  • A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy
  • An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumours, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
  • A Study of MabThera (Rituximab) Subcutaneous Vs. MabThera (Rituximab) Intravenous in Patients With Follicular Non-Hodgkin's Lymphoma
  • Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma Prostate
  • The Physical and Psychological Benefits of Yoga and Breast Cancer
  • Pre-Operative Assessment of Chest Wall Invasion in NSCLC Using Pre-Operative, Surgeon Performed Ultrasound
  • Thoracoscopic Localization of Pulmonary Nodules Using Direct Intracavitary Thoracoscopic Ultrasound
  • A Comparison of Contrast Enhanced Ultrasound (CEUS) and Contrast Enhanced Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) for Characterization of Focal Liver Masses
  • Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer
  • A Feasibility Study to Compare the Benefits of Endoscopic Tumour Clip Placement and 3T-MRI Simulation for Accurate Target Volume Definition for Rectal Cancer Patients Undergoing Pre-operative Chemoradiation
  • Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
  • A Study of Chemotherapy and Ramucirumab vs. Chemotherapy Alone in Second Line Non-small Cell Lung Cancer Patients Who Received Prior First Line Platinum Based Chemotherapy
  • Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)
  • Study Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia
  • Stereotactic Body Radiation Therapy (SBRT) for Spinal/Para-Spinal Metastases (Spine SBRT)
  • Surgery Versus Radiosurgery for the Treatment of Single Brain Metastases
  • Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumours
  • Phase 2 Study of Maintenance OSI-906 Plus Erlotinib (Tarceva®), or Placebo Plus Erlotinib in Patients With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy
  • Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
  • Radiation Therapy and Cisplatin in Treating Patients With Stage I Bladder Cancer
  • Volumetric Modulated Arc Therapy (VMAT) for Brain Metastases
  • Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients
  • Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
  • Study of Ramucirumab or IMC-18F1 With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma
  • Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: The RESPONSE Trial
  • A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB
  • A Study of Pemetrexed & Carboplatin/Cisplatin or Gemcitabine & Carboplatin/Cisplatin With or Without IMC-1121B in Patients Previously Untreated With Recurrent or Advanced Non-small Cell Lung Cancer (NSCLC)
  • Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
  • A Clinical Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
  • Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
  • Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
  • Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity
  • Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer
  • Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer
  • Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumours That Have Been Removed By Surgery
  • CT-validation of Ultrasound Based Planning for High Dose Rate (HDR) Prostate Brachytherapy Using Vitesse
  • Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast Cancer
  • The Natural History of Small Renal Masses
  • Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects With Advanced Solid Tumours.
  • BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)
  • A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
  • Safety Study Evaluating Intravenous Infusions of Tigecycline to Treat Acute Myeloid Leukemia
  • Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy
  • Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard Chemotherapy
  • Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma
  • A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy
  • Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • A Study of Obinutuzumab (RO5072759) in Combination With CHOP Chemotherapy Versus MabThera/Rituxan (Rituximab) With CHOP in Patients With CD20-Positive Diffuse Large B-Cell Lymphoma
  • A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With MabThera/Rituxan (Rituximab) Plus Chemotherapy Followed by GA101 or MabThera/Rituxan Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma
  • Facilitating Physical Activity Behaviour and Health Outcomes in Breast Cancer Patients Receiving Chemotherapy
  • Study of Oral MLN9708 in Combination With Melphalan and Prednisone in Patients With Newly Diagnosed Multiple Myeloma
  • Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumours or Lymphoma
  • Conventional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer Patients
  • Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Patients With Metastatic Breast Cancer: Duration of Effect
  • Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant
  • Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma
  • A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
  • Safety Evaluation of Dexmedetomidine for EBUS-TBNA
  • Effectiveness of Doxycycline for Treating Pleural Effusions Related to Cancer in an Outpatient Population
  • Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumours or Leukemia
  • A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
  • A Study of First-line Maintenance Tarceva (Erlotinib) Versus Tarceva at Time of Disease Progression in Patients With Advanced Non-small Cell Lung Cancer After Chemotherapy
  • Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis
  • Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences
  • Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
  • A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
  • A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
  • An Open-Label, Multi-Centre, Expanded Access Program With Eribulin for the Treatment of Advanced Breast Cancer Refractory
  • A Study of MK-1775 in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumours With the P53 Gene Mutation (MK-1775-004 AM4)
  • Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumour Response to Radiation Therapy in Breast Cancer
  • The ODYSSEY Study
  • A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumours
  • Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
  • Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
  • A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
  • MEK162 and RAF265 in Adult Patients With Advanced Solid Tumours Harbouring RAS or BRAFV600E Mutations
  • Femoral Bone Metastases
  • A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed Implant
  • FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy for High Risk Prostate Cancer
  • LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
  • Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
  • Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
  • PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC)
  • Stereotactic Ablative Radiation Therapy for Comprehensive Treatment of Oligometastatic Tumours (SABR-COMET)
  • The EPIC Study
  • Pilot Study of Partial Breast Irradiation Utilizing Permanent Breast Seed Implant to Treat Breast Cancer
  • Y90 Ibritumomab Tiuxetan Post R-CHOP Chemotherapy for Advanced Stage Follicular Lymphoma
  • An Exercise Trial for Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy
  • OPTIM DASATINIB
  • Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colon Cancer
  • A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
  • A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Patients With HER2-Positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-Directed Therapy (TH3RESA)
  • Study to Compare Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone Versus High-dose Dexamethasone in Subjects With Refractory or Relapsed and Refractory Multiple Myeloma
  • Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer
  • Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
  • Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in First-Line or in Switch Maintenance in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC)
  • Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
  • Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumours
  • Fosaprepitant (EMEND® IV) In Salvage Treatment of Chemotherapy-Induced Vomiting (MK-0517-030 AM1) (EVADE)
  • A Study on Patients' Preference of Herceptin (Trastuzumab) Subcutaneous Versus Intravenous Administration in Patients With HER2-Positive Early Breast Cancer
  • SPY-1
  • The Young Women's Breast Cancer Study
  • A phase I clinical study of BBI608 in adult patient with advanced solid tumours.
  • Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Patients Resistant to Aromatase Inhibitor Therapy
  • Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma
  • Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
  • A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumour or Hematologic Malignancy (V212-011 AM3)
  • A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia
  • Frameless Stereotactic Radiosurgery for Brain Metastases
  • A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
  • Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  • Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy
  • Efficacy of Optically-guided Surgery in the Management of Early-staged Oral Cancer - COOLS TRIAL
  • A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer
  • Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma
  • Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer
  • Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
  • A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer
  • Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
  • Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Refractory Myeloma
  • Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma
  • Active Surveillance Magnetic Resonance Imaging Study
  • Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule
  • Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer
  • Stereotactic Body Radiation Therapy (RT) for Non-Small Cell Lung Cancer
  • ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumours
  • Bone biopsy study
  • A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
  • A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer
  • A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma
  • Robotic Compared to Fixed Gantry Radiosurgery for Brain Metastases
  • A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With HM Receiving Treatment With Anti-CD20 Monoclonal Antibodies (V212-013)
  • Managing Cancer and Living Meaningfully (CALM): A Study to Evaluate the Effectiveness of a Psychological Intervention for Cancer Patients
  • LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
  • Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
  • Short Course vs. Standard Course Radiation Therapy in Elderly and/or Frail Patients With Glioblastoma Multiforme
  • NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
  • Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
  • Safety and Efficacy Study of Hypofractionated Radiation Therapy and Androgen Deprivation Therapy for Prostate Cancer
  • Breast Cancer and Exercise Trial in Alberta
  • Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
  • A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumours and Extensive Stage Small Cell Lung Cancer
  • Pilot Project of Adaptive Thoracic Radiation Therapy for Small Cell Lung Cancer
  • Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma
  • Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma
  • A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Patients With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung)
  • Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer
  • Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
  • A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy
  • A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function
  • Radiation Therapy in Treating Patients With Prostate Cancer
  • Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1)
  • Hypofractionated, Dose Escalation Radiation Therapy for High Risk Adenocarcinoma of the Prostate
  • A Study of Brentuximab Vedotin in Relapsed or Refractory CD30-positive Non-Hodgkin Lymphoma
  • Subcutaneous Lidocaine For Cancer-Related Pain
  • Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach
  • Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy
  • A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
  • SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
  • Integrated Molecular Profiling in Advanced Cancers Trial
  • An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)
  • Long Term Outcomes of Breast Intensity-Modulated Radiation Therapy
  • Levofloxacin in Preventing Infection in Young Patients Receiving Chemotherapy For Acute Leukemia or Undergoing Stem Cell Transplantation
  • Comparison of Dexmedetomidine and Propofol-Remifentanil Conscious Sedation for Awake Craniotomy for Tumour Surgery
  • A Trial of AMG 386 and Temsirolimus in Advanced Solid Tumours
  • A Phase II Multi-institutional Study Assessing Simultaneous In-field Boost Helical Tomotherapy for 1-3 Brain Metastases
  • Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
  • Imaging Study of Glioblastomas Treated With Avastin
  • Creating Meaning Following Cancer: An Intervention to Improve Existential and Global Quality of Life
  • Radiosensitization of AVASTIN® (Bevacizumab) With Stereotactic Body Radiation Therapy for Colorectal Liver Metastasis
  • Prostate Hypoxia FAZA
  • Sentinel Node Biopsy in Endometrial Cancer
  • Cervix Hypoxia FAZA
  • A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumours
  • Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients
  • Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery
  • Neoadjuvant Chemotherapy vs. Chemoradiation for Resectable Esophageal Cancer
  • Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumours (GI or Lung Origin)
  • TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
  • Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)
  • A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic Cancer
  • A Phase II Randomized Trial for Early-stage Squamous Cell Carcinoma of the Oropharynx: Radiation Therapy vs Trans-oral Robotic Surgery (ORATOR)
  • Laboratory Testing for Tie-2 Expressing Monocytes (TEMs) in Blood
  • The BEACON Study (Breast Cancer Outcomes With NKTR-102)
  • A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
  • A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
  • A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)
  • Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel
  • Self-Management Intervention for Breathlessness in Lung Cancer
  • Focal Salvage HDR Brachytherapy for the Treatment of Prostate Cancer
  • BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)
  • A Rollover Protocol for Subjects Previously Treated With AGS-003
  • Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
  • Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
  • Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor
  • Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
  • Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
  • Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot
  • Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients
  • Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery
  • Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
  • Conventional Versus Hypofractionated Radiation in High Risk Prostate Patients
  • Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced or Metastatic Solid Tumour Cancer
  • Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
  • LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
  • Prostate Accurately Targeted Radiation Therapy Investigation of Overall Treatment Time
  • Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
  • A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer
  • Study of Bevacizumab/mFOLFOX6 Versus Bevacizumab/Folfiri With Biomarker Stratification in Patients With Previously Untreated Metastatic Colorectal Cancer
  • Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components
  • Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
  • Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer
  • Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy
  • Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
  • Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)
  • Prospective Liver Tumour (ProLiT) Database
  • Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients
  • Polarized Reflectance Spectroscopy for Oral Lesions
  • Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)
  • A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
  • Shrinking Target Adaptive Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
  • Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumours or Leukemia
  • Study in Head and Neck Cancer
  • A Study in Head and Neck Cancer
  • High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule
  • Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
  • Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism
  • A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
  • A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
  • A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
  • Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer
  • Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma
  • Quality of Life and Dysphagia Following Palliative Stenting in Esophageal Cancer
  • A Study of Pertuzumab in Combination With Herceptin (Trastuzumab) and A Taxane in First-Line Treatment in Patients With HER2-Positive Advanced Breast Cancer (PERUSE)
  • Cervical Video Assisted Thoracoscopic Surgery (C-VATS)
  • A Randomized Controlled Comparative Study of Ultrasound-guided Paravertebral Blocks as Part of a Multimodal Regimen for Ambulatory Breast Cancer Surgery
  • Predicting Malignancy Using Endoluminal Ultrasound Characteristics in Mediastinal Lymph Nodes
  • A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
  • Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
  • Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumour, Liver Cancer, or Thyroid Cancer
  • Trying Activity in Kidney Cancer Survivors (TRACKS) Trial
  • A Clinical Study Conducted in Multiple Centres Comparing Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Subjects With Brain Metastases From Non Small Cell Lung Cancer (NSCLC)
  • Cancer, fertility and motherhood
  • Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL)
  • Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
  • A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
  • Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone
  • Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumours, Including Central Nervous System Tumours
  • Homeopathic Treatment of Fatigue in Children Receiving Chemotherapy
  • Nausea and Vomiting in Children Receiving Chemotherapeautic Monotherapy
  • Aromatase Inhibitor Host Factors Study
  • A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed Mantle Cell Lymphoma
  • A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma
  • A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing
  • A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumours
  • Study of the Predictive Marker FLT in Patients Suffering From AML
  • The Value of Botox-A for Management of Low Anterior Resection Syndrome
  • A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
  • Continuation Study of the Oral AKT Inhibitor GSK2110183
  • A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumours
  • Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression
  • Vitamin D Loading Dose in Advanced Lung Cancer
  • Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
  • Multimodal Prehabilitation for Colorectal Surgery
  • A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
  • Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
  • Study Evaluating the Safety and Efficacy Of Carboplatin/Paclitaxel And Carboplatin/Paclitaxel/Bevacizumab With and Without GDC-0941 in Patients With Previously Untreated Advanced Or Recurrent Non-small Cell Lung Cancer
  • A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands
  • A Safety and Tolerability Study of Assisted- and Self-Administered Subcutaneous Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With Early HER2-Positive Breast Cancer (SafeHer)
  • A Study of Vemurafenib Adjuvant Therapy in Patients With Resected Cutaneous BRAF Mutant Melanoma
  • Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-Small Cell Lung Cancer
  • A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer
  • A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Patients With Recurrent Glioblastoma
  • Radical Versus Simple Hysterectomy and Pelvic Node Dissection in Patients With Early Stage Cervical Cancer
  • A Study of Dalotuzumab + MK-2206 and Dalotuzumab + MK-0752 Combination Therapies in Participants With Advanced Cancer (MK-0646-027)
  • Study of Red Bull™ Sugar-Free Drink for Reduction of Fatigue in Prostate Cancer Patients Receiving LHRH Agonist Therapy
  • Non-Interventional Retrospective Correlation Of Tumour Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib
  • Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
  • A Study of Avastin (Bevacizumab) in Combination With Temolozomide (TMZ) and Radiation Therapy in Paediatric and Adolescent Patients With High-Grade Glioma
  • Study of PX-866 and Docetaxel in Solid Tumours
  • Safety Study of Monoclonal Antibody Ipilimumab in Cervical Cancer
  • EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
  • A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma
  • A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
  • A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  • A Combination Study of Trastuzumab Emtansine And Capecitabine in Patients With Breast Cancer Or Gastric Cancer
  • Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
  • Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer
  • Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiation Therapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
  • Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
  • LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer
  • Feasibility Study of Genomic Profiling Methods and Timing in Tumour Samples
  • A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia
  • Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
  • Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
  • LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib
  • A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumours
  • Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer
  • Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
  • Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos
  • MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumours and Non-Small Cell Lung Cancer
  • A Phase 3 Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma
  • A Study of Trastuzumab Emtansine in Patients With HER2 Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
  • A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.
  • Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumours
  • Firmagon (Degarelix) Intermittent Therapy
  • Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumours
  • Extended Dose - Total Body Irradiation Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory Acute Leukemia And Advanced Myelodysplastic Syndrome
  • First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma
  • Reolysin in Patients With Previously Treated Advanced or Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy
  • Multicentric Randomized Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus 5-fluorouracil, Leucovorin, Irinotecan and Oxaliplatin (mFolfirinox) in Patients With Resected Pancreatic Adenocarcinoma
  • A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer
  • Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Non-squamous NSCLC
  • Thermal Ablation in Larger Liver and Kidney Tumours
  • Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer
  • Urine Metabolomics and Colorectal Cancer Screening
  • A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumours That Express Nectin-4
  • A Phase 2, Multicentre, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
  • Optical Coherence Tomography for Monitoring Late Oral Radiation Toxicity After Radiation Therapy of Head and Neck Cancer Patients
  • Novel Controlled Hypo-Perfusion Technique in Partial Nephrectomy
  • Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
  • A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer
  • Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer
  • A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
  • OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone
  • Multiparametric MRI for Prostate Cancer Localization and Characterization: New Methods
  • A Study of DCDT2980S in Combination With MabThera/Rituxan or DCDS4501A in Combination With MabThera/Rituxan in Patients With Non-Hodgkin's Lymphoma
  • A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumour
  • A Study With Tasquinimod Treating Patients in Four Independent Cohorts of Hepatocellular, Ovarian, Renal Cell and Gastric Cancers
  • A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer
  • Exercise in Pediatric Autologous Stem Cell Transplant Patients
  • Comparing Robotics and Laparoscopy With Laparotomy/Open Surgery for Endometrial Cancer
  • The Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide or In Combination With Carboplatin and Paclitaxel Versus Placebo in Subjects With BRCA1 and BRCA2 Mutation and Metastatic Breast Cancer.
  • A Clinical Study Conducted in Multiple Centres Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer.
  • A Study of Patient Preference With Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Patients With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a
  • A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
  • Exercise and Nutrition for Head and Neck Cancer Patients
  • Efficacy and Safety Study of NeuVax(TM)(Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
  • Early Diagnosis of Pulmonary Nodules
  • RTOG 0920: A Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-advanced Resected Head and Neck Cancer
  • A Phase I Clinical Study of BBI608 in Adult Patients With Advanced Malignancies
  • Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer
  • A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate
  • Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin
  • Phase II Phosphatidylinositol 3-Kinase (PI3K) Inhibitor in Relapsed, Indolent or Aggressive Non-Hodgkin's Lymphomas (NHL)
  • Comparison of Surgical Approach to Endoscopic Pituitary Adenoma Resection
  • Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
  • A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology
  • A Phase I Clinical Study of BBI503 in Adult Patients With Advanced Solid Tumours
  • A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients
  • Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer
  • A Study of Vemurafenib Alone And Vemurafenib in Combination With GDC-0973 in Patients With Malignant Melanoma
  • Tumour TARGET Prostate Cancer
  • Early Palliative Care for Patients with Advanced Epithelial Ovarian Cancer
  • Stereotactic Radiation Therapy (SBRT) of Lung Metastasis
  • Utilization of Genomic Information to Augment Chemotherapy Decision-making for People With Incurable Malignancies
  • Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
  • Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
  • Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma
  • Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
  • Study of Zevalin Versus Observation in Patients at Least 60 Yrs Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in PET-negative Complete Remission After R-CHOP or R-CHOP-like Therapy
  • Study of BMS-936558 vs. Everolimus in Pre-Treated Advanced Or Metastatic Clear-cell RCC
  • A Phase II, Single Arm, Open Label Study of Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
  • Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
  • Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiation Therapy (SBRT)
  • Perspectives of Receiving Open Versus Minimally Invasive Surgery
  • Remote Ischemia Pre-Conditioning in Patients Undergoing Partial Nephrectomy
  • Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)
  • Mismatched Donor Cells to Treat Acute Myeloid Leukemia
  • Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
  • Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumour Patients
  • Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC)
  • ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas
  • A Study of RO5503781 as Single Agent or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
  • A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia
  • An Extension Study of RO5045337 in Patients Participating in Previous Cancer Studies
  • Combining Doxycycline With Bone-Targeted Therapy in Patients With Metastatic Breast Cancer
  • Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer
  • A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Patients With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)
  • BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Patients With Pretreated Advanced Colorectal Carcinoma
  • Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC
  • A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With Abiraterone